ClinicalTrials.gov record
Completed Phase 1 Interventional

Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia

ClinicalTrials.gov ID: NCT00004056

Public ClinicalTrials.gov record NCT00004056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Newly Diagnosed Childhood AML Using a Timed-Sequential Remission Induction and Consolidation Followed by Single Dose Melphalan With Peripheral Stem Cell Rescue: A POG Pilot Study

Study identification

NCT ID
NCT00004056
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Children's Oncology Group
Network
Enrollment
35 participants

Conditions and interventions

Conditions

Interventions

  • asparaginase Drug
  • cytarabine Drug
  • daunorubicin hydrochloride Drug
  • filgrastim Biological
  • melphalan Drug
  • peripheral blood stem cell transplantation Procedure
  • thioguanine Drug

Drug · Biological · Procedure

Eligibility (public fields only)

Age range
Up to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 1999
Primary completion
Sep 30, 2002
Completion
Feb 28, 2007
Last update posted
Jul 27, 2014

1999 – 2007

United States locations

U.S. sites
19
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294
Arizona Cancer Center Tucson Arizona 85724
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Lucile Packard Children's Hospital at Stanford Palo Alto California 94304
Children's Hospital and Health Center San Diego California 92123-4282
Nemours Children's Clinic Jacksonville Florida 32207
Emory University Hospital - Atlanta Atlanta Georgia 30322
Children's Memorial Hospital, Chicago Chicago Illinois 60614
Maine Children's Cancer Program Scarborough Maine 04074
Johns Hopkins Oncology Center Baltimore Maryland 21231
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Children's Hospital of Michigan Detroit Michigan 48201
Cardinal Glennon Children's Hospital St Louis Missouri 63104
Hackensack University Medical Center Hackensack New Jersey 07601
Tomorrows Children's Institute Hackensack New Jersey 07601
Mount Sinai School of Medicine New York New York 10029
Simmons Cancer Center - Dallas Dallas Texas 75235-9154
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104
Midwest Children's Cancer Center Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2014 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004056 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →